|
Originally published In Press as doi:10.1074/jbc.M410697200 on November 18, 2004
J. Biol. Chem., Vol. 280, Issue 5, 3938-3945, February 4, 2005
Cystic Renal Neoplasia Following Conditional Inactivation of Apc in Mouse Renal Tubular Epithelium*
Chao-Nan Qian ,
Jared Knol ,
Peter Igarashi ,
Fangming Lin¶,
Uko Zylstra||,
Bin Tean Teh , and
Bart O. Williams**
From the
Laboratories of Cancer Genetics and **Cell Signaling and Carcinogenesis, Van Andel Research Institute, Grand Rapids, Michigan 49508, the Departments of Internal Medicine and Division of Basic Sciences and ¶Pediatrics, University of Texas, Southwestern Medical Center, Dallas, Texas 75390, and the ||Department of Biology, Calvin College, Grand Rapids, Michigan 49546
Alterations in Wnt/ -catenin signaling have been linked to abnormal kidney development and tumorigenesis. To gain more insights into the effects of these alterations, we created mice carrying a conditional deletion of the Apc tumor suppressor gene specifically in the renal epithelium. As expected, the loss of Apc leads to increased levels of -catenin protein in renal epithelium. Most of these mice die shortly after birth, and multiple kidney cysts were found upon histological examination. Only rarely did these animals survive to adulthood. Analysis of these adults revealed severely cystic kidneys associated with the presence of renal adenomas. Our results confirm an important role for proper regulation of Wnt/ -catenin signaling in renal development and provide evidence that dysregulation of the pathway can initiate tumorigenesis in the kidney.
Received for publication, September 16, 2004
, and in revised form, November 18, 2004.
* This work was supported in part by National Institutes of Health Grants DK-42921, DK-57328, and DK-67565. Further support was provided by the Van Andel Research Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
 To whom correspondence should be addressed: Van Andel Research Institute, 333 Bostwick Ave., N.E., Grand Rapids, MI 49503. Tel.: 616-234-5308; Fax: 616-234-5309; E-mail: bart.williams{at}vai.org.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Z. S. Morris and A. I. McClatchey
Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma
PNAS,
June 16, 2009;
106(24):
9767 - 9772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Romaker, M. Puetz, S. Teschner, J. Donauer, M. Geyer, P. Gerke, B. Rumberger, B. Dworniczak, P. Pennekamp, B. Buchholz, et al.
Increased Expression of Secreted Frizzled-Related Protein 4 in Polycystic Kidneys
J. Am. Soc. Nephrol.,
January 1, 2009;
20(1):
48 - 56.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lal, X. Song, J. L. Pluznick, V. Di Giovanni, D. M. Merrick, N. D. Rosenblum, V. Chauvet, C. J. Gottardi, Y. Pei, and M. J. Caplan
Polycystin-1 C-terminal tail associates with {beta}-catenin and inhibits canonical Wnt signaling
Hum. Mol. Genet.,
October 15, 2008;
17(20):
3105 - 3117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Qian, L. Chen, A. A. Fernald, B. O. Williams, and M. M. Le Beau
A critical role for Apc in hematopoietic stem and progenitor cell survival
J. Exp. Med.,
September 1, 2008;
205(9):
2163 - 2175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cadieux, R. Harada, M. Paquet, O. Cote, M. Trudel, A. Nepveu, and M. Bouchard
Polycystic Kidneys Caused by Sustained Expression of Cux1 Isoform p75
J. Biol. Chem.,
May 16, 2008;
283(20):
13817 - 13824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Benzing, M. Simons, and G. Walz
Wnt Signaling in Polycystic Kidney Disease
J. Am. Soc. Nephrol.,
May 1, 2007;
18(5):
1389 - 1398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Bruxvoort, H. M. Charbonneau, T. A. Giambernardi, J. C. Goolsby, C.-N. Qian, C. R. Zylstra, D. R. Robinson, P. Roy-Burman, A. K. Shaw, B. D. Buckner-Berghuis, et al.
Inactivation of Apc in the Mouse Prostate Causes Prostate Carcinoma
Cancer Res.,
March 15, 2007;
67(6):
2490 - 2496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Yao, C.-N. Qian, Z.-F. Zhang, M.-H. Tan, E. J. Kort, X. J. Yang, J. H. Resau, and B. T. Teh
Two Distinct Types of Blood Vessels in Clear Cell Renal Cell Carcinoma Have Contrasting Prognostic Implications
Clin. Cancer Res.,
January 1, 2007;
13(1):
161 - 169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-L. Lin, J.-Y. Wang, Y.-T. Huang, Y.-H. Kuo, K. Surendran, and F.-S. Wang
Wnt/beta-Catenin Signaling Modulates Survival of High Glucose-Stressed Mesangial Cells
J. Am. Soc. Nephrol.,
October 1, 2006;
17(10):
2812 - 2820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Peruzzi, G. Athauda, and D. P. Bottaro
The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells
PNAS,
September 26, 2006;
103(39):
14531 - 14536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Haumaitre, M. Fabre, S. Cormier, C. Baumann, A.-L. Delezoide, and S. Cereghini
Severe pancreas hypoplasia and multicystic renal dysplasia in two human fetuses carrying novel HNF1{beta}/MODY5 mutations
Hum. Mol. Genet.,
August 1, 2006;
15(15):
2363 - 2375.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|